Saturday, May 23, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

Empowering patients to control their diseases with Charles Mattocks

Charles Mattocks is an Award-Winning actor, director, producer, television host and health advocate whose priority for health first and saving lives does not get in his way of excelling in all areas of the business. The nephew of the late great Bob Marley, Mattocks comes from a very high-profile family lineage. His work has been showcased with appearances on CNN, The Today Show, Dr. Oz, Fox News, Good Morning America, The Talk, The Martha Stewart Show and numerous media outlets worldwide.

Clips of his shows can be found below:

Eight days cancer series: https://www.youtube.com/watch?v=rmlHBN3Gfcg

Reversed tv series trailer: https://vimeo.com/224587982

Carnivore tv series trailer: https://www.youtube.com/watch?v=jr4asXbVVoY&t=7s

Our body is thy temple trailer: https://www.youtube.com/watch?v=4eAnhXoRNBg&t=12s

Keto series: https://www.youtube.com/watch?v=aa9LZ9sMDxc&t=7s

Trial by fire trailer: https://vimeo.com/152911789

#charles #mattocks #bob #marley #patient #empowerment #narrative #medicine

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Comments 0

  1. What an eye-opener!
    NED!!!!!!!! Those are the words we want to hear!
    Hallelujah!!!!!!!!

Leave a Reply

Your email address will not be published. Required fields are marked *

Videos

Policy Shift in Peptide Regulation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!